Vitamin D Used in Cancer Treatment

Vitamin D is known for its role in bone health and calcium metabolism, but recent research has also focused on its potential in cancer prevention and treatment. The active form of vitamin D, 1,25-dihydroxyvitamin D (calcitriol), has been studied for its effects on various types of cancer. Studies suggest that vitamin D may help apoptosis (programmed cell death), stop cancer cell growth, metastasis, and immune function. This shows the potential for Vitamin D to be used as an adjunct therapy in cancer treatment.

The benefits have been seen as an adjunct therapy in treating many different types of cancer. The type that shows the most promise is in treating Breast Cancer. Supplementing with Vitamin D has been studied and proven as a positive preventative measure in this type of cancer. It has also shown positive effects as a therapy used in addition to other cancer treatments such as Immunotherapy, and others. 

Vitamin D has many other health benefits that likely correlate to its effectiveness in treating and preventing cancer such as hormone regulation, and calcium absorption. When taken with Vitamin K2, the absorption effectiveness is increased further to promote the delivery of calcium to the bones.  

A person holding a translucent capsule pill in front of the sun against a cloudy sky.

    • Vitamin D helps regulate cell division and differentiation. Its active form, calcitriol, binds to the vitamin D receptor (VDR) in cells and can control the expression of genes involved in cell proliferation.

    • This mechanism may help slow the growth of cancer cells or stop them from dividing uncontrollably.

  • Vitamin D promotes apoptosis in abnormal cells. This ensures that damaged or cancerous cells are removed from the body before they can spread.

  • Vitamin D can reduce the formation of new blood vessels (angiogenesis) that supply nutrients to tumors. By cutting off this supply, tumor growth may be slowed.

    • Vitamin D enhances the activity of immune cells, such as T cells and macrophages, which play a role in detecting and destroying cancer cells.

    • It can also modulate inflammation, reducing chronic inflammation that might otherwise promote cancer development.

    • Some studies suggest that vitamin D may reduce the ability of cancer cells to invade surrounding tissues and metastasize to other parts of the body.

    • Vitamin D influences the expression of genes associated with DNA repair and oxidative stress, helping to maintain cellular integrity.

Cancer Types Studied

Research has looked into vitamin D's effects on several cancers, including:

  • Breast cancer

  • Colon cancer

  • Prostate cancer

  • Lung cancer

  • Skin cancers (e.g., melanoma)

Sunset over the ocean with clouds and gentle waves hitting the sandy shore.

Vitamin D for Treating Breast Cancer

The role of vitamin D in breast cancer treatment has been a particular focus of research, as some studies suggest that adequate levels of vitamin D may have a protective effect or even contribute to therapeutic outcomes in breast cancer patients.

    • Numerous studies have observed an inverse association between vitamin D levels and breast cancer risk. A meta-analysis published in the Journal of Clinical Oncology (2013) found that higher circulating levels of vitamin D were linked to a reduced risk of breast cancer, particularly in premenopausal women.

    • A study published in Cancer Causes & Control (2015) indicated that higher vitamin D levels at the time of breast cancer diagnosis were associated with better prognosis and lower rates of recurrence and mortality.

    • Vitamin D and its active form, calcitriol, exert anticancer effects in breast cancer cells through multiple mechanisms:

      • Inducing Apoptosis: Vitamin D can induce programmed cell death in breast cancer cells, particularly in those with VDR expression.

      • Inhibiting Proliferation: Calcitriol has been shown to inhibit the growth of breast cancer cells by disrupting the cell cycle, particularly by preventing the transition from G1 to S phase.

      • Regulation of Oncogenes: Vitamin D can downregulate the expression of certain oncogenes, such as HER2, which is associated with aggressive forms of breast cancer.

      • Inhibiting Metastasis: Vitamin D may inhibit the invasion and metastasis of breast cancer cells, potentially by regulating matrix metalloproteinases (MMPs) involved in tissue degradation.

    • Combination with Chemotherapy: Preclinical studies have suggested that combining vitamin D with chemotherapy could enhance the efficacy of certain chemotherapeutic agents. A study published in Breast Cancer Research and Treatment (2012) found that calcitriol sensitized breast cancer cells to the effects of tamoxifen (a common breast cancer drug).

    • Clinical Trials: Clinical trials examining the role of vitamin D supplementation in breast cancer treatment have been somewhat limited, but several studies are ongoing. Some findings suggest that vitamin D may help mitigate the side effects of chemotherapy and radiation therapy, such as bone loss, by promoting bone health and reducing inflammation.

    • Vitamin D Receptor (VDR) Status: The effectiveness of vitamin D in treating breast cancer may depend on the expression of the vitamin D receptor in tumor cells. Studies have found that breast cancer cells with high VDR expression are more likely to respond to vitamin D treatment.

    • Low levels of vitamin D at the time of breast cancer diagnosis have been associated with a poorer prognosis, increased recurrence, and higher mortality rates. A study published in The American Journal of Clinical Nutrition (2014) suggested that vitamin D deficiency in breast cancer patients could lead to a higher risk of metastasis, especially in hormone receptor-negative subtypes.

    • Conversely, higher vitamin D levels before diagnosis have been linked to improved survival and a reduced risk of metastasis. This has led to speculation that maintaining adequate vitamin D levels might be beneficial during and after breast cancer treatment.

    • While vitamin D is generally considered safe at moderate levels, high doses (above 4000 IU per day) can lead to toxicity, resulting in hypercalcemia (elevated calcium levels), kidney damage, and other health problems. Careful monitoring is required, especially in cancer patients, as they may already be at higher risk for kidney and calcium metabolism issues due to chemotherapy or other treatments.

PROS

Pros of Using Vitamin D in All Types of Cancer Treatment

  • Studies suggest that adequate vitamin D levels may lower the risk of developing several types of cancer, including colorectal, breast, prostate, and ovarian cancers. Higher vitamin D levels have been associated with a reduced incidence of cancer in some observational studies.

  • Vitamin D can promote apoptosis (programmed cell death) in cancer cells, particularly those with vitamin D receptors (VDR), potentially leading to the destruction of malignant cells.

  • Vitamin D has been shown to slow cancer cell growth by regulating the cell cycle, preventing cells from proliferating uncontrollably. This can limit tumor growth and spread.

  • Vitamin D modulates the immune system, boosting the activity of T-cells, macrophages, and other immune cells. This can enhance the body’s natural defense against cancer cells and improve the efficacy of immunotherapies.

  • When used alongside chemotherapy, radiation, or hormone therapies, vitamin D may sensitize cancer cells to these treatments, potentially improving their effectiveness. For example, it may enhance the action of chemotherapy drugs like tamoxifen in breast cancer.

  • Higher vitamin D levels at the time of diagnosis have been associated with better outcomes in certain cancers, including reduced rates of recurrence, metastasis, and improved overall survival.

  • Many cancer treatments, such as chemotherapy and hormone therapies (e.g., aromatase inhibitors), can lead to bone loss. Vitamin D helps maintain bone density and may reduce the risk of bone fractures and osteoporosis, which is crucial for cancer patients undergoing such therapies.

  • Vitamin D supplementation is affordable, widely available, and easy to incorporate into a treatment regimen, making it a cost-effective adjunct therapy for cancer patients.

  • At appropriate levels, vitamin D is considered safe and generally free from significant side effects, making it a low-risk addition to cancer treatment strategies.

  • Chronic inflammation is associated with cancer progression. Vitamin D may help modulate inflammatory responses, which could potentially slow cancer development or improve patient outcomes.

  • Vitamin D has been shown to influence the tumor microenvironment, potentially inhibiting tumor growth and metastasis by altering the behavior of surrounding tissues and immune cells.

  • Early research suggests that vitamin D may help improve the effectiveness of immune checkpoint inhibitors and other immunotherapies by modulating the immune system, which is a promising area of ongoing cancer treatment research.

Summary: The use of vitamin D in cancer treatment offers several potential benefits, including its ability to reduce cancer risk, inhibit tumor growth, enhance immune function, and improve treatment outcomes when combined with other therapies. However, more research is needed to refine its use in clinical practice, particularly in determining optimal doses and identifying which patients will benefit the most.

CONS

The Cons of Vitamin D Use in Cancer Treatment

While vitamin D shows promise in cancer treatment, there are several potential cons and limitations to its use. Here’s a breakdown of the concerns:

    • Inconsistent Results: While some studies suggest a protective or therapeutic effect of vitamin D, others show minimal or no benefit. The role of vitamin D in cancer treatment is still not fully understood, and more robust clinical trials are needed.

    • Variability in Response: Different cancers, stages of cancer, and individual patient factors (e.g., genetics, baseline vitamin D levels) affect outcomes, making it difficult to generalize findings.

    • Hypercalcemia: High doses of vitamin D can lead to excessive calcium levels in the blood, causing symptoms such as nausea, vomiting, kidney damage, confusion, and arrhythmias.

    • Long-Term Risks: Chronic high-dose supplementation could harm the kidneys or increase the risk of calcification in soft tissues.

    • Patients may mistakenly view vitamin D as a substitute for proven cancer treatments like chemotherapy, radiation, or immunotherapy. This could delay or compromise the effectiveness of evidence-based interventions.

    • Mismanagement of supplementation without medical guidance could exacerbate toxicity or interfere with other treatments.

  • Vitamin D may interact with certain cancer therapies, potentially altering their effectiveness. For instance:

    • It may enhance the effect of some drugs.

    • It could also dampen the effectiveness of others if not properly dosed or timed.

    For example, calcitriol (the active form of vitamin D) may increase sensitivity to certain chemotherapy agents, but this effect is not universal.

    • Uncertainty about Optimal Dose: While maintaining adequate vitamin D levels is important, the "ideal" dose for cancer treatment is unclear. The range between a therapeutic dose and a toxic dose can be narrow.

    • Over-supplementation may be risky, especially for patients with existing conditions such as kidney disease or hyperparathyroidism.

  • The effectiveness of vitamin D may vary significantly depending on the type of cancer. For example:

    • Promising results have been seen in breast and colon cancers.

    • However, evidence is weaker for cancers like lung or pancreatic cancer.

  • Vitamin D’s effects on cellular processes may help slow cancer development or early progression, but its benefits in late-stage or metastatic cancers appear limited.

  • Vitamin D supplementation may only benefit those who are deficient in it. Patients with adequate baseline levels may not see additional benefits, making supplementation unnecessary in some cases.

  • In rare cases, studies have indicated that high doses of vitamin D could promote cancer cell growth or resistance to apoptosis under specific conditions, though these findings are not well understood.

  • Observational studies showing links between higher vitamin D levels and lower cancer risk may be confounded by lifestyle factors. For instance, people with higher vitamin D levels may spend more time outdoors, exercise more, or follow a healthier diet, all of which independently affect cancer outcomes.

Summary: Vitamin D is not a cure for cancer, and its use as part of cancer treatment is still under investigation. While it can support overall health and potentially enhance certain therapies, the risks of toxicity, lack of standardized dosing, and uncertain effectiveness make it critical for patients to use vitamin D only under medical supervision.

The higher dosage level that is usually advised during cancer treatment can range from 12,000 - 15,000 IU. However, depending on the individual and their vitamin intake levels, taking around 12,000 - 60,000 international units (IU) a day of vitamin D for several months has been shown to cause toxicity. This level is many times higher than the recommended daily recommendations and what is considered to be a safe higher dose as mentioned. The U.S. Recommended Dietary Allowance (RDA) for most adults of 600 IU of vitamin D a day. 

Toxicity symptoms include loss of appetite, vomiting, kidney problems, and others. This is why it’s ideal to have it administered under supervision.

References

Here is a list of various medical journals and clinical trials that have been completed on the use of Vitamin D for treating cancer.

Dandelions in a field during sunset with warm, golden sunlight.

Below are some key clinical trials and findings related to the use of vitamin D for cancer treatment.

    • Trial Title: Effect of Vitamin D3 on Survival in Patients with Advanced or Metastatic Breast Cancer (D-Breast)

    • Study ID: NCT02252752

    • Study Type: Phase II, randomized, controlled trial

    • Status: Completed

    • Location: Several treatment centers worldwide

    • Objective: This study investigated whether vitamin D3 supplementation could improve survival in patients with advanced or metastatic breast cancer. The primary goal was to evaluate the effects of vitamin D on progression-free survival.

    • Results: The findings of this trial are not yet fully published, but early results suggested a potential benefit in improving overall survival. Further analysis is needed to determine if vitamin D3 supplementation can slow disease progression or enhance the effects of other treatments.

    • Trial Title: Randomized Trial of Vitamin D3 Supplementation for Chemotherapy-Treated Cancer Patients

    • Study ID: NCT02485416

    • Study Type: Randomized, double-blind trial

    • Status: Completed

    • Location: University of California, San Francisco (UCSF)

    • Objective: This study explored whether vitamin D3 supplementation improves survival and quality of life in cancer patients receiving chemotherapy. The trial aimed to determine if supplementation could reduce cancer-related fatigue and improve overall health outcomes in patients with breast cancer.

    • Results: The trial showed that vitamin D supplementation was well tolerated, but the effects on survival and quality of life were mixed. While some patients experienced improved fatigue scores, survival outcomes were not conclusively improved in the breast cancer group.

    • Trial Title: The Effect of Vitamin D3 on Immune Function and Inflammation in Cancer Patients (VITD-Ca)

    • Study ID: NCT01902734

    • Study Type: Randomized, placebo-controlled trial

    • Status: Completed

    • Location: University of Texas MD Anderson Cancer Center

    • Objective: This trial investigated whether vitamin D3 supplementation could enhance immune function in cancer patients, with a focus on inflammatory markers, immune cells, and tumor progression.

    • Results: The study showed that vitamin D3 supplementation positively influenced certain immune system markers and reduced systemic inflammation in cancer patients. However, the study did not definitively show a reduction in tumor size or progression. It suggested that vitamin D might enhance the immune response, which could indirectly affect cancer growth.

    • Trial Title: Effect of Vitamin D3 on Recurrence-Free Survival in Patients with Colorectal Cancer (D3-Ca)

    • Study ID: NCT01174492

    • Study Type: Phase III, randomized trial

    • Status: Completed

    • Location: National Cancer Institute (NCI), USA

    • Objective: This large-scale trial investigated whether vitamin D3 supplementation could prevent recurrence in patients who have undergone surgery for stage II or III colorectal cancer.

    • Results: This trial found that vitamin D3 supplementation did not significantly improve recurrence-free survival. However, patients who had higher baseline vitamin D levels before the study had better overall survival outcomes, suggesting a possible association between baseline vitamin D status and prognosis.

    • Trial Title: Vitamin D3 as an Adjunct to Chemotherapy in Non-Small Cell Lung Cancer Patients

    • Study ID: NCT02966305

    • Study Type: Phase II, double-blind, placebo-controlled

    • Status: Active, recruiting participants

    • Location: Multiple centers in Europe

    • Objective: This ongoing trial is evaluating the effects of vitamin D3 supplementation on progression-free survival in NSCLC patients receiving standard chemotherapy. The study also aims to explore changes in immune function and inflammation markers in response to supplementation.

    • Expected Outcome: While preliminary data is not available, researchers are hopeful that vitamin D3 supplementation may enhance immune function and improve the effectiveness of chemotherapy in lung cancer patients.

    • Trial Title: VITAL: A Trial of Vitamin D and Omega-3 for Cancer Prevention

    • Study ID: NCT01109234

    • Study Type: Large-scale, randomized, placebo-controlled trial

    • Status: Completed

    • Location: Multiple centers across the US

    • Objective: The VITAL trial is a large study investigating whether vitamin D supplementation (2000 IU/day) can reduce the incidence of various types of cancer, including breast cancer. It also explores whether it has an effect on cancer mortality.

    • Results: The VITAL trial results showed a modest reduction in cancer mortality in those who received vitamin D supplementation, although the effects on breast cancer incidence specifically were not as pronounced. The study emphasized the importance of adequate vitamin D levels in maintaining overall health, especially in preventing cancer in the first place.

    • Trial Title: Vitamin D3 for Prostate Cancer: Effects on Treatment Outcomes

    • Study ID: NCT02119769

    • Study Type: Phase II, randomized, controlled trial

    • Status: Completed

    • Location: Multiple centers in the UK

    • Objective: This trial assessed the effects of vitamin D3 on prostate cancer patients undergoing active surveillance or on androgen deprivation therapy (ADT).

    • Results: Preliminary findings suggested that vitamin D supplementation did not significantly alter disease progression or PSA levels in prostate cancer patients. However, the study highlighted the potential for vitamin D to enhance the immune response and influence the tumor microenvironment in cancer treatment.

    • Trial Title: The Effect of Vitamin D Supplementation on Chemotherapy-Induced Peripheral Neuropathy

    • Study ID: NCT03518893

    • Study Type: Randomized, double-blind, placebo-controlled trial

    • Status: Recruiting

    • Location: Multiple centers in Canada

    • Objective: This study explores whether vitamin D supplementation can reduce the severity of chemotherapy-induced peripheral neuropathy, a common side effect in cancer patients, including those with breast cancer.

    • Expected Outcome: Researchers hope that vitamin D may help alleviate some of the debilitating side effects of chemotherapy, thereby improving patients' quality of life during treatment.

    • Epidemiological Studies: Observational studies have suggested a correlation between higher levels of vitamin D and a lower risk of developing certain cancers, including colorectal, breast, prostate, and ovarian cancers.

      • A meta-analysis published in the American Journal of Preventive Medicine (2014) showed a significant inverse relationship between serum vitamin D levels and cancer risk. Specifically, higher levels of vitamin D were associated with reduced risks of colorectal cancer and other cancers.

      • The International Journal of Cancer (2014) found that individuals with higher vitamin D levels had lower risks of developing breast cancer.

    • Mechanism of Action: Vitamin D exerts its anticancer effects primarily through its active form, calcitriol. It can regulate gene expression via the vitamin D receptor (VDR), which is expressed in many types of cancer cells. Vitamin D influences cell cycle regulation, apoptosis (programmed cell death), differentiation, and metastasis.

    • In laboratory studies, calcitriol has been shown to induce apoptosis and inhibit proliferation in various cancer cell lines, including prostate, breast, lung, and colon cancer cells.

    • Vitamin D also appears to affect angiogenesis (the formation of new blood vessels), which is crucial for tumor growth.

    • Although observational studies are promising, clinical trials investigating vitamin D supplementation as an adjunct treatment for cancer have yielded mixed results. Some trials suggest that vitamin D supplementation may reduce cancer-related mortality or slow progression, while others have found no significant effect.

      • A randomized controlled trial published in JAMA Oncology (2019) found that high-dose vitamin D supplementation did not significantly reduce the risk of cancer or cancer mortality in individuals without cancer at baseline.

    • However, in a study published in the American Journal of Clinical Nutrition (2011), vitamin D supplementation combined with calcium was associated with a reduced incidence of cancer in postmenopausal women.

    • Vitamin D plays a crucial role in modulating the immune system, which may influence cancer progression. The active form of vitamin D enhances the antimicrobial and immune regulatory functions of immune cells, such as macrophages and T-cells.

    • Recent research suggests that vitamin D may improve the effectiveness of immune checkpoint inhibitors, a class of cancer therapies. It is hypothesized that vitamin D's immune-modulating effects could enhance the antitumor response when used alongside immunotherapy.


Summary of Vitamin D in Cancer Treatment

For General Cancer Treatment: Vitamin D shows promise as a potential adjunct in cancer prevention and treatment. Its role in modulating immune function, regulating cell growth, and inducing apoptosis makes it a compelling candidate for further research. However, more large-scale, randomized clinical trials are needed to confirm its therapeutic efficacy.

  • For Breast Cancer: The research on vitamin D for breast cancer treatment is particularly promising, with some studies suggesting that adequate levels of vitamin D may reduce cancer risk, improve prognosis, and enhance the effects of chemotherapy. However, vitamin D supplementation should be approached with caution, particularly regarding optimal dosing and potential toxicity.

More research is needed to define the appropriate dosing, timing, and patient populations who would benefit most from vitamin D supplementation or treatment in the context of cancer.

Key Takeaways

  • Vitamin D Supplementation has been explored in various clinical trials as a possible adjunct to traditional cancer treatments. While some trials have shown promising results in improving immune function and possibly enhancing treatment outcomes, others have not found significant benefits in reducing tumor progression or recurrence.

  • Cancer Types: Most research has been conducted in breast cancer, colorectal cancer, lung cancer, and prostate cancer, with mixed findings.

  • Ongoing Trials: Many trials are still ongoing or in the planning stages, especially in terms of understanding how vitamin D interacts with chemotherapy and immunotherapy.

Conclusion

Although there is promising evidence that vitamin D may have a role in improving cancer prevention and outcomes, further research is needed to determine its effectiveness, optimal dosing, and specific applications in cancer treatment. If you are considering vitamin D supplementation as part of cancer treatment, it is crucial to consult your oncologist or work together as a team with a naturopathic doctor or practitioner to tailor the approach for your specific needs and treatment regimen.

Disclaimer:

The information provided on this website is for educational and informational purposes only and is not intended as medical advice. While we strive to provide accurate, up-to-date information on various cancer therapies, including both traditional and alternative options, this content should not be used as a substitute for professional medical consultation, diagnosis, or treatment.

We strongly recommend that users consult with qualified healthcare providers before making any healthcare decisions, including but not limited to: starting or stopping any new or existing cancer treatments. Every individual’s health situation is unique, and only a licensed medical professional can provide tailored guidance.

Our goal is to inform and empower, but we cannot guarantee the effectiveness or safety of any therapy discussed on this site. Reliance on any information provided by this website is solely at your own risk.

Some content on this website has been generated or assisted by artificial intelligence, and then has been internally reviewed. Any resemblance to copyrighted material is purely coincidental and unintentional. If you believe any content infringes on intellectual property rights, please contact us for resolution.